Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) Stock Ticker

NASDAQ: VOR · Healthcare · Biotechnology
$18.52+0.43%
USD · as of 2026-09-28 · market cap $1.0B
Open VOR in TickrDownload for iPhone

VOR right now

Options expect by Oct 6±10.9%
Options expect by Oct 29±22.6%
Priced in for Nov 12 earnings±27.4%
IV rank (30-day)11% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full VOR picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on VOR
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Vor Biopharma Inc.

Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.

VOR stock facts

Ticker symbolVOR
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$1.0B
CEOJean-Paul Kress
Employees76
HeadquartersBoston, MA, US
IPO date2021-02-05
Websitewww.vorbio.com

What you can see for VOR on Tickr

Live VOR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the VOR report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Vor Biopharma Inc.?

The ticker symbol for Vor Biopharma Inc. is VOR, listed on the NASDAQ Global Select.

What is VOR?

Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature…

HomeExploreMarketLists
All pages